Lantus and Rituximab and hyaluronidase human, recombinant Subcutaneous
Determining the interaction of Lantus and Rituximab and hyaluronidase human, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Lantus, Lantus Solostar Pen, Basaglar KwikPen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: n.a.
Generic Name: hyaluronidase / rituximab
Brand name: Rituxan Hycela
Synonyms: Hyaluronidase and rituximab, Rituximab and Hyaluronidase
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lantus-Rituximab Intravenous
- Lantus-Riva-Amoxicillin
- Lantus-Rivaroxaban
- Lantus-Rivastigmine
- Lantus-Rivastigmine Capsules
- Lantus-Rivastigmine Oral Solution
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Lantus SoloStar
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Lantus SoloStar (Insulin Glargine (U-100) Cartridge Systems and Pens)
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Lantus Solostar (Insulin Glargine (U-300) Pens)
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Lantus Solostar Pen
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Lapatinib
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Lapatinib Ditosylate